Anchiano Therapeutics Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 3

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 10

  • Investments
  • 1

Anchiano Therapeutics General Information

Description

Operator of a biopharmaceutical firm intended for the discovery, development and commercialization of novel targeted therapies to treat cancer. The company specializes in the treatment of various cancer cures such as non-muscle-invasive bladder, advanced malignant neoplasms, metastatic lung and metastatic liver treatments.

Contact Information

Formerly Known As
BioCancell, BioCancell Therapeutics
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • One Kendall Square, Building 1400 East
  • Suite 14-105
  • Cambridge, MA 02139
  • United States
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • One Kendall Square, Building 1400 East
  • Suite 14-105
  • Cambridge, MA 02139
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Anchiano Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Anchiano Therapeutics‘s full profile, request access.

Request a free trial

Anchiano Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biopharmaceutical firm intended for the discovery, development and commercialization of novel targeted the
Drug Discovery
Cambridge, MA
3 As of 2020

Thousand Oaks, CA
 

Rahway, NJ
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Anchiano Therapeutics Competitors (3)

One of Anchiano Therapeutics’s 3 competitors is Amgen, a Formerly PE-Backed company based in Thousand Oaks, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Amgen Formerly PE-Backed Thousand Oaks, CA
Merck & Co. Corporation Rahway, NJ
Boehringer Ingelheim Corporation Ingelheim Am Rhein, Germany
You’re viewing 3 of 3 competitors. Get the full list »

Anchiano Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Anchiano Therapeutics Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Anchiano Therapeutics‘s full profile, request access.

Request a free trial

Anchiano Therapeutics Acquisitions (1)

Anchiano Therapeutics’s most recent deal was a Reverse Merger with Chemomab Therapeutics for . The deal was made on 16-Mar-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Chemomab Therapeutics 16-Mar-2021 Reverse Merger Drug Discovery
To view Anchiano Therapeutics’s complete acquisitions history, request access »

Anchiano Therapeutics Exits (1)

Anchiano Therapeutics’s most recent exit was on 16-Mar-2021 from Chemomab Therapeutics. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Chemomab Therapeutics 16-Mar-2021 Completed
To view Anchiano Therapeutics’s complete exits history, request access »

Anchiano Therapeutics FAQs

  • When was Anchiano Therapeutics founded?

    Anchiano Therapeutics was founded in 2004.

  • Where is Anchiano Therapeutics headquartered?

    Anchiano Therapeutics is headquartered in Cambridge, MA.

  • What is the size of Anchiano Therapeutics?

    Anchiano Therapeutics has 3 total employees.

  • What industry is Anchiano Therapeutics in?

    Anchiano Therapeutics’s primary industry is Drug Discovery.

  • Is Anchiano Therapeutics a private or public company?

    Anchiano Therapeutics is a Private company.

  • What is Anchiano Therapeutics’s current revenue?

    The current revenue for Anchiano Therapeutics is .

  • How much funding has Anchiano Therapeutics raised over time?

    Anchiano Therapeutics has raised $61.8M.

  • Who are Anchiano Therapeutics’s investors?

    Arc Ventures (United States), Clal Biotechnology Industries, Hebrew University of Jerusalem Endowment, Palisade Capital Management, and Shavit Capital are 5 of 7 investors who have invested in Anchiano Therapeutics.

  • Who are Anchiano Therapeutics’s competitors?

    Amgen, Merck & Co., and Boehringer Ingelheim are competitors of Anchiano Therapeutics.

  • When was Anchiano Therapeutics acquired?

    Anchiano Therapeutics was acquired on 16-Mar-2021.

  • Who acquired Anchiano Therapeutics?

    Anchiano Therapeutics was acquired by Chemomab Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process